No Data
No Data
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Vivani Medical (VANI) and Merit Medical Systems (MMSI)
Wells Fargo Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
Truist Financial Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $110
Boston Scientific Updates Instructions for Cryoablation Balloons After Reports Of Severe Injuries
J.P. Morgan's Top Healthcare Stocks for 2025
No Data